Global Polymerase Chain Reaction Technologies and (2021 to 2026) – Featuring Abbott Laboratories, Bioneer and Qiagen Among Others -…

DUBLIN, September 02, 2021--(BUSINESS WIRE)--The "Polymerase Chain Reaction (PCR) Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global market for PCR technology should grow from $10.5 billion in 2021 to $13.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.

The reagents and consumables market for PCR technology should grow from $6.3 billion in 2021 to $8.4 million by 2026, at a CAGR of 6.0% for the period of 2021-2026.

The software market for PCR technology should grow from $590.8 million in 2021 to $776.1 million by 2026, at a CAGR of 5.6% for the period of 2021-2026.

This report examines the market potential of PCR technology. It offers a detailed analysis of the competitive environment, regulatory scenario, technological advances, drivers and restraints, and opportunity and trends in market growth. The report also covers market projections to 2026 and market rankings for key players. The report discusses the market share of PCR technologies based on type of product, technology and application.

This report segments the global market by four geographical regions: North America, Europe, Asia-Pacific and the Rest of the World (RoW). For the purpose of this report, North America includes the U.S., Canada and Mexico; the European region includes Germany, U.K., France and Rest of Europe; the Asia-Pacific region includes China, India, Japan, and the Rest of Asia-Pacific; and RoW includes the Middle East, Africa and South America. For market estimates, data is provided for the year 2020 as the base year, 2019 as the historical year and forecasts are through year-end 2026.

Companies Mentioned

Abbott Laboratories

Agilent Technologies Inc.

Becton, Dickinson And Co.

Bio-Rad Laboratories Inc.

Biofire Diagnostics Llc

Bioneer Corp.

Eppendorf Ag

F. Hoffmann-La Roche Ltd.

Qiagen Nv

Thermo Fisher Scientific Inc.

Report Includes

70 data tables and 15 additional tables

An updated review of the global market for polymerase chain reaction (PCR) technologies

Analyses of the global market trends, with data from 2019-2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026

Discussion of major factors driving the growth of the PCR market, industry structure, regulatory scenario, and penetration of technologies in molecular diagnosis of infectious diseases

Estimation of market size and revenue sales forecast for PCR products, and corresponding market share analysis by product, technology type, application, and geographic region

Impact of the COVID-19 on the market for PCR technology, R&D efforts and the need to reinvent medical ventilators, current status and impact on Medtech

Highlights of emerging technology trends, opportunities and gaps estimating current and future demand for PCR technology in clinical diagnostics

Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances or other advantages

Competitive landscape of the major players operating in the global market, their competitive environment and product portfolio analysis

Key Topics Covered:

Story continues

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Background and Technology Overview

Evolution of PCR

Principles of PCR

Instruments and Components of PCR

Instruments

Target DNA

Primers

Enzyme and Enzyme Concentration

Buffers

Magnesium Concentration

Deoxyribonucleoside Triphosphates

Types of PCR

Reverse Transcription PCR

Nested PCR

Hot Start and Touchdown PCR

Inverse PCR

Multiplex PCR

Quantitative PCR

Traditional vs. Real-Time PCR

Design of Primer for PCR

Primer Selection

Primer Length

Melting Temperature

Specificity

G/C Content

3' End Sequence

PCR Quantification Methods

Absolute Quantification

Relative Quantification

Components of Quantitative PCR

DNA Binding Dyes

Probes in qPCR

Controls for qPCR Experiments

Chapter 4 COVID-19 and R&D

Potential Targets for COVID-19 Drug Development

Basigin (CD147)

C-C Chemokine Receptor Type 5 (CCR5)

Envelope Protein (E) (SARS-CoV-2; COVID-19)

Epithelial Sodium Channel (ENaC)

Histamine N-Methyltransferase (HMT)

Interleukin-6 Receptor Subunit ? (IL-6RA)

Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19)

Nucleocapsid (N) (SARS-CoV-2; COVID-19)

R&D on COVID-19

COVID-19 Clinical Trial Landscape

Chapter 5 Regulatory Structure of the COVID-19 Diagnostics Industry

Coronavirus Treatment Acceleration Program (CTAP)

Clinical Trials being Conducted during COVID-19 Pandemic

Response to Drug Shortages

National Regulatory Agencies for Ongoing Clinical Trials

U.S. FDA

Medicines and Healthcare Products Regulatory Agency (U.K.)

European Medicines Agency

COVID-19 Testing

Chapter 6 Polymerase Chain Reaction: Market Dynamics

Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Chapter 7 Impact of COVID-19 Pandemic

Outbreak

Progression of COVID-19

Incubation Period

Epidemiology

Collaboration Between Organizations and Governments

Spread of Disease

Current Status and Impact on Medical Technology

Elective and Noncritical Procedures

Shift in Manufacturing

Continued here:

Global Polymerase Chain Reaction Technologies and (2021 to 2026) - Featuring Abbott Laboratories, Bioneer and Qiagen Among Others -...